Scope and purpose | The overall objective(s) of the guideline is (are) specifically described | 5.6 (1.6) | 5.7 (1.4) |
The health question(s) covered by the guideline is (are) specifically described | 5.7 (1.4) |
The population (patients, public etc.) to which the guideline is meant to apply is specifically described | 5.8 (1.3) |
Stakeholder involvement | The guideline development group includes individuals from all relevant professional groups | 5.3 (1.5) | 4.8 (2.0) |
The views and preferences of the target population (patients, public, etc.) have been sought | 3.3 (2.1) |
The target users of the guideline are clearly defined | 5.9 (1.2) |
Rigour of development | Systematic methods were used to search for evidence | 4.5 (2.1) | 4.8 (2.0) |
The criteria for selecting the evidence are clearly described | 4.5 (2.2) |
The strengths and limitations of the body of evidence are clearly described | 4.1 (2.0) |
The methods for formulating the recommendations are clearly described | 5.4 (1.4) |
The health benefits, side effects and risks have been considered in formulating the recommendations | 5.1 (1.8) |
There is an explicit link between the recommendations and the supporting evidence | 5.2 (1.6) |
The guideline has been externally reviewed by experts prior to its publication | 4.0 (2.3) |
A procedure for updating the guideline is provided | 5.7 (1.8) |
Clarity of presentation | The recommendations are specific and unambiguous | 5.7 (1.2) | 5.7 (1.3) |
The different options for management of the condition or health issue are clearly presented | 5.5 (1.5) |
Key recommendations are easily identifiable | 5.8 (1.4) |
Applicability | The guideline describes the facilitators and barriers to its application | 4.3 (1.8) | 4.3 (1.9) |
The guideline provides advice and/or tools on how the recommendation can be put into practice | 5.3 (1.3) |
The potential resource implications of applying the recommendations have been considered | 3.7 (2.1) |
The guideline presents the monitoring and/or auditing criteria | 3.8 (1.9) |
Editorial independence | The views of the funding body have not influenced the content of the guideline | 5.4 (1.8) | 5.6 (1.6) |
Competing interests of the guideline development group members have been recorded and addressed | 5.9 (1.4) |